Phase 1 Prostate Cancer Trial, Recruiting (NCT04186585)

Phase 1 Prostate Cancer Trial, Recruiting NCT04186585 Sponsor: Meddoc Condition: Prostate Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT04186585 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Prostate Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with prostate cancer and are between 18 and 80 years old
You are currently receiving hormonal treatment for your prostate cancer

Who may not be able to join:

Your doctors estimate that you are not expected to live for more than 3 months
Your liver is not working as it should, based on blood test results showing certain values are too high (confirm with trial site)
Your kidneys are not working as they should, based on a specific blood test result being too high (confirm with trial site)
You have cancer that has spread to your brain
You have another type of cancer at the same time, unless it is a certain type of skin cancer or an early stage of cervical cancer
You have an abnormal heart reading on an ECG (a test that checks your heart's electrical activity)
You are currently receiving radiation therapy
You have taken steroid tablets or other drugs that suppress your immune system within the last 3 weeks
You have taken part in another clinical drug trial within the last 6 weeks
You are not able to understand the information provided about the trial
You are unwilling or unable to sign a written consent form to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 7 July 2026

Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Svein Aa Ingelholm, PhD, Meabco A/S

Phone: +47 41326325

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04186585

Sponsor: Meddoc

Phase: Phase 1

Status: Recruiting

Condition: Prostate Cancer

Trial contact: +47 41326325

More information: https://clinicaltrials.gov/study/NCT04186585

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with prostate cancer and are between 18 and 80 years old
You are currently receiving hormonal treatment for your prostate cancer

Who may not be able to join:

Your doctors estimate that you are not expected to live for more than 3 months
Your liver is not working as it should, based on blood test results showing certain values are too high (confirm with trial site)
Your kidneys are not working as they should, based on a specific blood test result being too high (confirm with trial site)
You have cancer that has spread to your brain
You have another type of cancer at the same time, unless it is a certain type of skin cancer or an early stage of cervical cancer
You have an abnormal heart reading on an ECG (a test that checks your heart's electrical activity)
You are currently receiving radiation therapy
You have taken steroid tablets or other drugs that suppress your immune system within the last 3 weeks
You have taken part in another clinical drug trial within the last 6 weeks
You are not able to understand the information provided about the trial
You are unwilling or unable to sign a written consent form to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 7 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 1

Sponsor

Meddoc

Registry

ClinicalTrials.gov

Start date

1 April 2023

Est. completion

1 August 2025

Where this trial is recruiting

🇳🇴 Norway

Primary endpoints

Max CTCAE; Max CTCAE; Max CTCAE; Max CTCAE; Max CTCAE; Sum CTCAE score; Sum CTCAE score; Sum CTCAE score; Sum CTCAE score; Sum CTCAE score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov